GX-G3, a long-acting G-CSF, compared with pegfilgrastim in reducing duration of severe neutropenia after chemotherapy for non-Hodgkin's lymphoma.

Ertan-Ahmed, SenemKiehl, Michael G.Radinoff, AtanasGraklanov, VaskoTzvetkov, NikolayMihaescu, RodicaSung, Young ChulTurgut, Burhan2022-05-112022-05-1120190732-183X1527-7755https://hdl.handle.net/20.500.11776/8811Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- MAY 31-JUN 04, 2019 -- Chicago, IL[No Abstract Available]eninfo:eu-repo/semantics/closedAccessGX-G3, a long-acting G-CSF, compared with pegfilgrastim in reducing duration of severe neutropenia after chemotherapy for non-Hodgkin's lymphoma.Conference Object3715Q1WOS:000487345802410